Table 2.
Severe COVID-19 | |||
---|---|---|---|
Number of vaccinations | Patients | Vaccine effectiveness* | |
n/total (%) | percent (95% CI) | ||
All | 0 | 54/34,097 (0.2%) | Reference |
1 | 2/705 (0.3%) | −3.5% [−301.7-73.4] | |
2 | 37/30,134 (0.1%) | 55.5% [32.6-71.7] | |
3 | 57/25,540 (0.2%) | 76.9% [66.7-84.0] | |
4 | 19/2,174 (0.9%) | 75.7% [58.8-85.7] | |
Over 65 | 0 | 50/953 (5.3%) | Reference |
1 | 2/37 (5.4%) | −4.6% [−308.0-73.2] | |
2 | 35/1,418 (2.5%) | 52.5% [27.2-69.0] | |
3 | 54/4,391 (1.2%) | 77.0% [66.4-84.2] | |
4 | 19/1,414 (1.3%) | 76.5% [60.1-86.2] |
*Adjusted for age, sex, comorbidities, obesity, pregnancy, and smoking status. CI: confidence interval